These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 11884494)

  • 41. Treatment of heterotopic ossification after spinal cord injury.
    Banovac K; Gonzalez F; Renfree KJ
    J Spinal Cord Med; 1997 Jan; 20(1):60-5. PubMed ID: 9097258
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Indomethacin versus meloxicam for prevention of heterotopic ossification after total hip arthroplasty.
    Legenstein R; Bösch P; Ungersböck A
    Arch Orthop Trauma Surg; 2003 Apr; 123(2-3):91-4. PubMed ID: 12664317
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Refractory heterotopic ossification with complications.
    Yin KS; James J; Lew K; Little JW
    J Spinal Cord Med; 2001; 24(2):119-22. PubMed ID: 11587419
    [TBL] [Abstract][Full Text] [Related]  

  • 44. False-negative triple-phase bone scans in spinal cord injury to detect clinically suspect heterotopic ossification: a case series.
    Svircev JN; Wallbom AS
    J Spinal Cord Med; 2008; 31(2):194-6. PubMed ID: 18581667
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.
    van der Heide HJ; Rijnberg WJ; Van Sorge A; Van Kampen A; Schreurs BW
    Acta Orthop; 2007 Feb; 78(1):90-4. PubMed ID: 17453398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heterotopic ossification about the elbow: a therapist's guide to evaluation and management.
    Casavant AM; Hastings H
    J Hand Ther; 2006; 19(2):255-66. PubMed ID: 16713872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurogenic heterotopic ossification.
    Jensen LL; Halar E; Little JW; Brooke MM
    Am J Phys Med; 1987 Dec; 66(6):351-63. PubMed ID: 3124630
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clarifying the structure and bone mineral content of heterotopic ossification.
    Isaacson BM; Brown AA; Brunker LB; Higgins TF; Bloebaum RD
    J Surg Res; 2011 May; 167(2):e163-70. PubMed ID: 21392799
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of immature heterotopic ossification (HO) of the hip.
    Jamil F; Subbarao JV; Banaovac K; El Masry WS; Bergman SB
    Spinal Cord; 2002 Aug; 40(8):388-95. PubMed ID: 12124665
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Radiation prophylaxis for heterotopic ossification of the knee.
    Chidel MA; Suh JH; Matejczyk MB
    J Arthroplasty; 2001 Jan; 16(1):1-6. PubMed ID: 11172262
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Radiation therapy for heterotopic ossification prophylaxis].
    Utzon H; Skov O; Johansen J
    Ugeskr Laeger; 2014 Jun; 176(24):. PubMed ID: 25352198
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterotopic ossification: a systematic review.
    Edwards DS; Clasper JC
    J R Army Med Corps; 2015 Dec; 161(4):315-21. PubMed ID: 25015927
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Computerized quantitative radionuclide assessment of heterotopic ossification in spinal cord injury patients.
    Kim SW; Wu SY; Kim RC
    Paraplegia; 1992 Nov; 30(11):803-7. PubMed ID: 1484734
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The traumatic bone: trauma-induced heterotopic ossification.
    Dey D; Wheatley BM; Cholok D; Agarwal S; Yu PB; Levi B; Davis TA
    Transl Res; 2017 Aug; 186():95-111. PubMed ID: 28668522
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and efficacy of radiation therapy as secondary prophylaxis for heterotopic ossification of non-hip joints.
    Mishra MV; Austin L; Parvizi J; Ramsey M; Showalter TN
    J Med Imaging Radiat Oncol; 2011 Jun; 55(3):333-6. PubMed ID: 21696569
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk factors for heterotopic ossification in spinal cord injury.
    Lal S; Hamilton BB; Heinemann A; Betts HB
    Arch Phys Med Rehabil; 1989 May; 70(5):387-90. PubMed ID: 2497715
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short-term treatment with nonsteroidal antiinflammatory medications to prevent heterotopic bone formation after total hip arthroplasty. A preliminary report.
    Kjaersgaard-Andersen P; Ritter MA
    Clin Orthop Relat Res; 1992 Jun; (279):157-62. PubMed ID: 1600651
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heterotopic ossification mimicking acute arthritis after neurologic catastrophes.
    Goldberg MA; Schumacher HR
    Arch Intern Med; 1977 May; 137(5):619-21. PubMed ID: 404975
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Breakdown of spontaneous fused bilateral hip with heterotopic ossification to staged bilateral total hip arthroplasty through a direct lateral approach: A case report.
    Aldhafian OR; Alenazi BR; Mohammed AM; Khairi HE; Bin Nwihadh N
    Int J Surg Case Rep; 2020; 77():467-471. PubMed ID: 33395827
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostaglandin E2 measurements: their value in the early diagnosis of heterotopic ossification in spinal cord injury patients.
    Schurch B; Capaul M; Vallotton MB; Rossier AB
    Arch Phys Med Rehabil; 1997 Jul; 78(7):687-91. PubMed ID: 9228869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.